Astellas

An arrow incrementally going up stairs before pointing straight up Blue background
Pharma

Keytruda, Padcev keep winning streak in bladder cancer

The PD-1/ADC combo showed an overall survival benefit as a perioperative treatment in patients with cisplatin-eligible muscle-invasive bladder cancer.
Angus Liu Dec 17, 2025 9:53am
Asia

FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia

Dec 5, 2025 8:45am
FDA

Padcev, Keytruda combo scores game-changing FDA nod

Nov 21, 2025 1:22pm
newspaper

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am
Bayer

Bayer scores FDA nod for nonhormonal menopause drug

Oct 24, 2025 3:23pm
On target clinical trial success bullseye score

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

Oct 18, 2025 10:30am